Page 126 - bandung_Neat

Judul : Indonesia currently developing its own Red and White vaccine:
Jokowi

Nama Media : antaranews.com

Tanggal : 11 Agustus 2020
Halaman/URL: https://en.antaranews.com/news/153918/indonesia-currently-
developing-its-own-red-and-white-vaccine-jokowi

Tipe Media : Media Online

Jakarta (ANTARA) - President Joko Widodo
(Jokowi) spoke of the government currently
developing and working on two vaccines,
specifically the Sinovac vaccine in cooperation
with China, and the Red and White vaccine being
entirely made in Indonesia.

Jokowi stated at the Padjajaran University
(Unpad) Teaching Hospital, Bandung, West Java,
on Tuesday that the Red and White vaccine was being entirely developed by
Indonesian institutions: the Eijkman Institution, Agency for the Assessment and
Application of Technology (BPPT), Indonesian Institute of Sciences (LIPI), Food and
Drug Supervisory Agency (BPOM), the Ministry of Research and Technology, and
universities.

Jokowi paid a visit to Bandung to witness the third stage clinical trial of the COVID-19
vaccine from Sinovac that Indonesian state-owned pharmaceutical company Bio
Farma will produce, while clinical trials are being conducted by a team from the Faculty
of Medicine of Unpad.

"For the past three months, we have been developing our own vaccine by isolating the
virus) that causes COVID-19 that has been spreading in Indonesia," the president
stated.

The head of state affirmed that the Red and White vaccine was projected to be ready
in mid-2021.
"Furthermore, we are open to establishing cooperation with others, for instance with
Sinovac from China and then with the United Arab Emirates in the G-42 and with South
Korea. I think we are opening up, so that all Indonesian people can be vaccinated as
quickly as possible," he noted.

Jokowi was optimistic about Bio Farma conducting massive production of the Sinovac
vaccine in January 2021 after six-month-long clinical trial processes.

"As we know it could produce approximately 100 million vaccines in August, and by
the end of the year, in December, production will increase to 250 million vaccines. This
means these vaccines will be utilized for vaccination in Indonesia," he stated.